Differing efficacy of beta blockers on long-term clinical outcomes between ischemic heart failure patients with reduced and mid-range ejection fraction following percutaneous coronary intervention.
Persistent higher high sensitivity C-reactive protein after percutaneous coronary intervention (PCI) predicts higher mortality in patients undergoing PCI with stable coronary artery disease.
